Pediatrix Medical Group, Inc. (BMV:MD)

Verve Therapeutics Statistics

Total Valuation

BMV:MD has a market cap or net worth of MXN 20.43 billion. The enterprise value is 26.09 billion.

Market Cap	20.43B
Enterprise Value	26.09B

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	84.21M
Shares Outstanding	n/a
Shares Change (YoY)	+2.21%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	83.14M

Valuation Ratios

The trailing PE ratio is 9.86 and the forward PE ratio is 7.38.

PE Ratio	9.86
Forward PE	7.38
PS Ratio	0.56
PB Ratio	1.30
P/TBV Ratio	n/a
P/FCF Ratio	4.77
P/OCF Ratio	4.43
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.18, with an EV/FCF ratio of 6.09.

EV / Earnings	12.59
EV / Sales	0.72
EV / EBITDA	5.18
EV / EBIT	6.45
EV / FCF	6.09

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.78.

Current Ratio	1.80
Quick Ratio	1.74
Debt / Equity	0.78
Debt / EBITDA	2.44
Debt / FCF	2.86
Interest Coverage	5.59

Financial Efficiency

Return on equity (ROE) is 14.27% and return on invested capital (ROIC) is 9.22%.

Return on Equity (ROE)	14.27%
Return on Assets (ROA)	6.50%
Return on Invested Capital (ROIC)	9.22%
Return on Capital Employed (ROCE)	12.09%
Revenue Per Employee	8.88M
Profits Per Employee	503,120
Employee Count	4,120
Asset Turnover	0.95
Inventory Turnover	n/a

Taxes

In the past 12 months, BMV:MD has paid 597.88 million in taxes.

Income Tax	597.88M
Effective Tax Rate	22.39%

Stock Price Statistics

The stock price has increased by +97.26% in the last 52 weeks. The beta is 1.21, so BMV:MD's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	+97.26%
50-Day Moving Average	385.22
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.44
Average Volume (20 Days)	6,700

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.35

Income Statement

In the last 12 months, BMV:MD had revenue of MXN 36.60 billion and earned 2.07 billion in profits. Earnings per share was 24.40.

Revenue	36.60B
Gross Profit	8.91B
Operating Income	4.02B
Pretax Income	2.67B
Net Income	2.07B
EBITDA	4.46B
EBIT	4.02B
Earnings Per Share (EPS)	24.40

Balance Sheet

The company has 6.57 billion in cash and 12.25 billion in debt, giving a net cash position of -5.68 billion.

Cash & Cash Equivalents	6.57B
Total Debt	12.25B
Net Cash	-5.68B
Net Cash Per Share	n/a
Equity (Book Value)	15.72B
Book Value Per Share	184.63
Working Capital	5.13B

Cash Flow

In the last 12 months, operating cash flow was 4.61 billion and capital expenditures -331.21 million, giving a free cash flow of 4.28 billion.

Operating Cash Flow	4.61B
Capital Expenditures	-331.21M
Free Cash Flow	4.28B
FCF Per Share	n/a

Margins

Gross margin is 24.36%, with operating and profit margins of 10.97% and 5.66%.

Gross Margin	24.36%
Operating Margin	10.97%
Pretax Margin	7.30%
Profit Margin	5.66%
EBITDA Margin	12.20%
EBIT Margin	10.97%
FCF Margin	11.70%

Dividends & Yields

BMV:MD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.21%
Shareholder Yield	n/a
Earnings Yield	10.15%
FCF Yield	20.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 20, 2013. It was a forward split with a ratio of 2.

Last Split Date	Dec 20, 2013
Split Type	Forward
Split Ratio	2

Scores

BMV:MD has an Altman Z-Score of 1.8 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.8
Piotroski F-Score	8